The Cannabist Company Holdings Inc. is launching the brand dreamt in Maryland, with additional markets and products to follow in 2025. 

Earlier this year, the company acquired the brand through its acquisition of the Ciencia Labs portfolio.

The dreamt brand offers unique formulations, which include a precise ratio of THC to CBD, in addition to supplements including GABA, and valerian root.

“dreamt is a transformative product, and we couldn’t be more excited to bring these highly sought after products to our shelves,” said Jesse Channon, president, The Cannabist Company. “Everyone deserves a good night's sleep to feel refreshed and be at their best. dreamt products will utilize our high-quality cannabis to make a positive impact in people’s daily lives, as we strive to bring innovation and excellence to our markets.”

dreamt is available as a 5 mg THC, 2 mg CBD, 1 mg CBN gummy sold in a 20 pack, at Columbia Care Chevy Chase and gLeaf dispensaries in Maryland and across the company’s wholesale channels.

“dreamt is the result of extensive formulation development,” said Blake Brower, VP, national operations, The Cannabist Company. “Our goal was to produce these products at our state-of-the-art facilities across multiple markets and provide our patients and customers with a consistent and reliable experience. We’re proud of our ability to maximize our facility's capabilities and supply these high-quality products in the most demanded product category.”